First Page | Document Content | |
---|---|---|
Date: 2009-03-31 15:45:56Hematology Biology Erythropoietin Darbepoetin alfa Epoetin alfa Amgen Anemia Hemoglobin Clinical trial Medicine Erythropoiesis-stimulating agents Growth factors | Submitted Aranesp USPI Aranesp For Injection (darbepoetin alfa)Add to Reading ListSource URL: www.accessdata.fda.govDownload Document from Source WebsiteFile Size: 672,98 KBShare Document on Facebook |
Reprint from January 8, 2007 BioCentury THE BERNSTEIN REPORT ARTICLE REPRINTDocID: 13F1b - View Document | |
REPRINTED WITH PERMISSION Business DayDocID: 13gi3 - View Document | |
Original Investigation A Randomized, Placebo-Controlled Trial of Pentoxifylline on Erythropoiesis-Stimulating Agent Hyporesponsiveness in Anemic Patients With CKD: The Handling Erythropoietin Resistance With OxpentifylliDocID: YO7g - View Document | |
BMC Nephrology BioMed Central Open AccessDocID: XoWc - View Document | |
STATISTICAL ANALYSIS PLAN (Version[removed]Protocol Title: A randomised, placebo-controlled trial of oxpentifylline onDocID: XouS - View Document |